Health News Releases

  • Today December 4
October 03, 2023 11:27
Boehringer Ingelheim and ZEISS join forces to early detect eye diseases and prevent vision loss
Boehringer Ingelheim and ZEISS Medical Technology announce today a long-term strategic collaboration to develop predictive analytics to enable early detection of eye diseases and prevent vision loss f
October 01, 2023 10:45
Organon Recognized on Fortune’s 2023 Change the World List for Leadership in Expanding Access to Contraceptive Choice
Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, has been named to Fortune’s 2023 Change the World list for its leadership in helping women and girls around the world t
September 27, 2023 10:40
Medisca Takes Steps to Protect its Innovative Technologies
Through decades of strategic research and development (“R&D”) investment, the Medisca name has become synonymous with innovative, customer-focused technologies. In compounding, for example, Medisca co
September 26, 2023 10:25
Korean Unicorn APR Files for Preliminary IPO Review on KRX
APR (https://www.apr-in.com/), a beauty-tech company APR (CEO Byung-hoon Kim) announced today that it filed for a preliminary review on the Korea Exchange (KRX) on September 22. Shinhan Securities
September 26, 2023 10:15
Aster Guardians Global Nursing Award 2024 is Now Open for Entry Worldwide, One Nurse Will Win the US $250,000 Award
In its continued efforts to recognize the contribution of nurses to humanity and the healthcare community, Aster DM Healthcare has announced the third edition of the Aster Guardians Global Nursing Awa
September 24, 2023 11:15
Kenvue to Announce Third Quarter 2023 Results on October 26, 2023
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, will announce its financial results for the third quarter ending October 1, 2023, before market o
September 22, 2023 10:25
ReNAgade Therapeutics Named to the 2023 Endpoints 11
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced that it has been named as one of the Endpoints 11 companies of 2023 (https://endpts.com/the-endpoi
The 41st Geumsan World K-Insam Festival Poster
September 21, 2023 10:00
41st Geumsan World K-Insam Festival to Kick Off with a Variety of Festivities on October 6
The 41st Geumsan World K-Insam Festival (https://www.kdischool.ac.kr/board.es?mid=a10603000000&bid=0011&list_no=16746&act=view) will take place in Geumsan from October 6 to 15, 2023, to promote the ef
September 20, 2023 16:48
MRM Health Reports Positive Topline Results from Phase 2a Clinical Study with MH002 in Mild-to-Moderate Ulcerative Colitis
MRM Health NV, a clinical-stage biopharmaceutical company focused on developing next-generation live microbiome consortia therapeutics, today reports positive topline results from its Phase 2a clinica
Portrait Dr. Rudolf Widmann/ AOP Health Group/ credit: Studio Koekart: Natascha Unkart & Isabelle Kö
September 20, 2023 15:05
Blood Cancer: AOP Health Announces New Findings in Patients With Polycythemia Vera Published in Medical Journal Leukemia
AOP Orphan Pharmaceuticals GmbH (AOP Health) announced the publication of final results on the recently developed interferon therapy, ropeginterferon alfa-2b, in patients with polycythemia vera (PV) i
September 20, 2023 14:29
Merck Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery
Merck, a leading science and technology company, today announced two new strategic drug discovery collaborations aimed at harnessing powerful artificial intelligence (AI)-driven design and discovery c
September 20, 2023 13:20
Julie Gerardi Joins Parse Biosciences as Vice President of Business Development
Parse Biosciences, (https://www.parsebiosciences.com/) a leading provider of accessible and scalable single cell sequencing solutions, today announced that Julie Gerardi has joined the company as vice
September 20, 2023 09:55
Takeda Commits Over $30 Million in Five New Global CSR Partnerships To Further Drive Health Impact in 92 Countries
Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced five new partnerships to its Global Corporate Social Responsibility (CSR) Program, which contribute to strengthe
James Burt, CEO, Pharmanovia (Photo: Business Wire)
September 19, 2023 10:10
Pharmanovia Acquires Global Central Nervous System (CNS) Portfolio From Sanofi
PRESS RELEASE - FOR TRADE, BUSINESS AND MEDICAL MEDIA ONLY Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises, extends and expands the lifecycle of est
RenMice Series and Their Drug Discovery Applications (Graphic: Business Wire)
September 17, 2023 15:40
Biocytogen Officially Launches RenMice® Series
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) officially announces the RenMice® series, which includes a collection of independently developed, fully human antibody mice a
September 15, 2023 13:20
SK Capital Completes Strategic Investment in Ecopol
Ecopol S.p.A. (“Ecopol” or the “Company”), a leading developer and producer of innovative biodegradable films and delivery systems, announced today the completion of a strategic investment from affili
September 14, 2023 17:18
Boehringer Ingelheim receives SBTi validation for CO2 reduction targets
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, said on Thursday it is well on track to achieve its 2030 emission reduction targets, and that it had received approval of tho
September 14, 2023 16:55
Ahead of UN General Assembly, pharmaceutical industry underscores need for pandemic preparedness plans to support innovation and equity
Ahead of discussions at the United Nations General Assembly (UNGA78), the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has warned that current pandemic preparednes
A Future Biogas biomethane plant (Photo: Business Wire)
September 14, 2023 16:19
AstraZeneca advances UK clean heat and energy efficiencies with £100m commitment
Powering AstraZeneca’s transition to net zero, the Company has agreed a 15-year partnership with Future Biogas to establish the UK’s first unsubsidised industrial-scale supply of biomethane gas, and i
September 14, 2023 09:45
ReNAgade Therapeutics Appoints Laurie Stelzer as Chief Financial Officer
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced the appointment of Laurie Stelzer as Chief Financial Officer. Ms. Stelzer most recently served as
(Photo: Business Wire)
September 13, 2023 11:20
KBI Biopharma, Inc. Expands Global Portfolio with Launch of SUREmAb™ for Faster Monoclonal Antibody Development and Manufacturing
KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the launch of SUREmAb (https://www.kbibiopharma.com/suremab-efficient-antibody-development)™, an offering built on the robustnes
September 12, 2023 16:10
Monrol Announces Investment to Expand its n.c.a. Lu-177 Production Capacity
Eczacıbaşı Monrol Nuclear Products Co. (Monrol), one of the world’s leading radiopharmaceutical producers, has decided to invest 35 million Euros to increase its production capacity for non-carrier-ad
September 12, 2023 10:20
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Company has completed the phase I clinical trial for its
September 12, 2023 09:33
Takeda Announces Positive Topline Results from Phase 2b Study Evaluating TAK-279, a Highly Selective Oral TYK2 Inhibitor, for the Treatment of Active Psoriatic Arthritis
Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced positive topline results from its randomized, double-blind, placebo-controlled, multiple-dose Phase 2b trial eva
Bifidobacterium longum subsp. longum BB536, a clinically effective and well-established multifunctio
September 08, 2023 15:45
Morinaga Milk’s Probiotic Bifidobacterium longum subsp. longum BB536 Receives ANVISA Approval with Gut Health Functional Claim in Brazil
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, is pleased to announce that its proprietary probiotic strain Bifidobacterium longum subsp. longum BB536 (hereaf
September 08, 2023 11:10
Biocytogen Enters into Antibody Evaluation, Option and License Agreement with Myricx for ADC Development
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotech company focusing on the discovery of novel antibody therapeutics, today announces an antibody evaluation, o
Jorge Cortell - Advisory Board Member Lysando AG
September 08, 2023 10:05
Lysando Welcomes Healthcare Visionary Jorge Cortell to its Advisory Board
Lysando, leading biotech in antimicrobial proteins, proudly announces the addition of Mr. Jorge Cortell to its esteemed Advisory Board marking a significant milestone in the company’s growth. As a ser
September 06, 2023 13:45
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that its Board of Directors (the “Board of Directors”) unani
September 06, 2023 11:15
Organon Bolsters Research & Development Expertise with Two Leadership Appointments
Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, today announced the appointment of Juan Camilo Arjona Ferreira, M.D., as Chief Medical Officer (CMO) and Charlotte Owen
(Logo: LabGenomics)
September 06, 2023 09:11
LabGenomics USA LLC Acquires QDx Pathology in a Strategic Move to Expand its Diagnostic Lab Services and IVD Diagnostic Products Business into the US Market
LabGenomics USA, a subsidiary of LabGenomics Co., Ltd., announced its acquisition of QDx Pathology, a leader in molecular and diagnostic pathology. The acquisition is expected to have significant impl
BioMice Business Summary (Graphic: Business Wire)
September 01, 2023 11:00
Biocytogen Establishes Two Business Divisions To Distinguish Preclinical Models and Services (BioMice) from Antibody Drug R&D
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announces the official formation of two major business divisions to represent the company’s product, service, and asset
August 30, 2023 13:45
Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, confirmed today that it is aware of an unsolicited partial tender offer from
August 29, 2023 09:45
Sinovac Announces Change of Legal Representative of Sinovac Beijing
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that the Company’s subsidiary, Sinovac Biotech Co., Ltd. (“S
August 28, 2023 13:45
SUSMED’s DTx Approved in Japan for the Treatment of Insomnia
SUSMED, Inc. (TOKYO:4263) announced that it obtained regulatory approval from the Ministry of Health, Labour and Welfare (the “MHLW”) of SUSMED Med CBT-i® App for Insomnia (the “product”). SUSMED is i
August 25, 2023 14:40
Thermo Fisher Scientific Announces the Launch of the EXENT® Solution with IVDR Certification
Thermo Fisher Scientific, the world leader in serving science, today announced the commercial launch of the EXENT® Solution, after receiving IVDR certification[*]. The EXENT solution is a fully integr
August 24, 2023 15:45
Royalty Pharma and Ferring Pharmaceuticals Enter into US $500 million Royalty Agreement for New Intravesical Gene Therapy Adstiladrin® (nadofaragene firadenovec-vncg)
Royalty Pharma plc (Nasdaq: RPRX) and Ferring Pharmaceuticals today announced that Royalty Pharma has acquired a synthetic royalty on US net sales of Ferring’s Adstiladrin® (nadofaragene firadenovec-v
August 24, 2023 09:15
Kenvue Becomes a Fully Independent Company Following Final Separation from Johnson & Johnson
Kenvue Inc. (NYSE: KVUE) (“Kenvue”) today announced its separation from Johnson & Johnson, marking its first day as a fully independent company. “This is a historic moment for Kenvue and with a sin
August 23, 2023 13:15
Crown Bioscience Enables HanX Biopharmaceutical to Progress HX009 to Clinical Trials
Crown Bioscience, a global contract research organization (CRO) and JSR Life Sciences company, has announced that its collaborative work with HanX Biopharmaceutical Co., Ltd. (“HanX”), employing a uni
August 23, 2023 10:30
BaroPace, Inc. Announced First Patient Enrolled in Non-Pharmacologic Hypertension and Heart Failure Treatment Trial
BaroPace Inc., a medical device company focused on the development of PressurePace™, a real-time physiologic control software and hardware to regulate cardiac pacemakers to treat resistant hypertensio
Masimo Root® with PVi® and SpHb® (Photo: Business Wire)
August 22, 2023 14:10
New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Elderly Patients Undergoing Gastrointestinal Surgery
Masimo (NASDAQ: MASI) today announced the findings of a prospective, randomized study published in Perioperative Medicine in which Dr. Yu Wang and colleagues at institutions in Shenzhen, Shaoguan, and
August 22, 2023 09:00
Apollon Collaborates with Laser Biomedical Research Center of MIT to Develop Continuous Non-Invasive Glucose Monitoring Technology
Apollon Inc., a medtech startup based in Seoul, will collaborate with the Laser Biomedical Research Center (LBRC) at the Massachusetts Institute of Technology (MIT) with the aim of developing and cond
August 20, 2023 09:45
Biocytogen’s Project Integrum Achieves Milestone Progress, Accelerating Antibody Business Growth
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) announced today that its Project Integrum has completed 2 core milestones, and its antibody business is now entering a new st
August 18, 2023 11:30
RoslinCT Announces the Appointment of Dr. Derek Hei to its Scientific Advisory Board
RoslinCT, a leading contract development and manufacturing organization (CDMO) for Advanced Cell and Gene therapies, announced the appointment of Derek Hei, Ph.D., to its Scientific Advisory Board (SA
August 13, 2023 10:35
CAS and Molecule.one Announce a Strategic Collaboration to Accelerate Drug Discovery
CAS, a division of the American Chemical Society specializing in scientific information solutions, and Molecule.one, a tech-bio leader in AI-based solutions for pharmaceutical chemistry, have establis
August 11, 2023 10:35
KBI Biopharma, Inc. Continues to Strengthen Leadership and Expertise With Key Executive Appointments
KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced four recent executive appointments to continue its momentum and vision of becoming a next-generation CDMO. Joining the company a
August 10, 2023 11:10
Now Health International Celebrates Another Service Success
Award-winning International Private Medical Insurance (IPMI) provider Now Health International is celebrating its latest customer service success, having won another prestigious award, Customer Servic
August 09, 2023 09:40
Graminex® Rye Pollen Achieves Novel Food Registration in China and Appoints Guangzhou Narnia Biotechnology as Their Authorized Distribution Partner
Graminex® announced today that it has achieved novel food registration in China for Rye Pollen and appointed Guangzhou Narnia Biotechnology as its distribution partner in China. Graminex®, based in
Duchenne Muscular Dystrophy (DMD); Progress of disease & gradual disability with aging, current ther
August 07, 2023 13:55
Promising disease modifying approach to Duchenne muscular dystrophy with Neu-REFIX® Beta 1,3-1,6 glucan* from Japan; the first such clinical report
Duchenne Muscular Dystrophy (DMD) patients showed signs of disease progress slowing down, after oral consumption of Neu REFIX ß-glucan for 45 days along with routine medications. Clinical improvements
August 03, 2023 16:15
The World Health Organization Includes the Cardiovascular Polypill Developed by the Spanish National Centre for Cardiovascular Research and Ferrer in its List of Essential Medicines
The cardiovascular polypill developed by the Spanish National Centre for Cardiovascular Research (CNIC) and Ferrer has been included by the World Health Organization (WHO) in its List of Essential Med
August 01, 2023 16:24
First half of 2023: Boehringer Ingelheim sees strong growth and expansion in key therapy areas
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, continues to advance its pipeline in both Human Pharma and Animal Health expanding across its key therapy areas. Currency-
25 per page50 per page75 per page100 per page